No Picture
News

Halozyme Announces First Clinical Dosing In argenx’s Phase 1 Trial Of Efgartigimod (ARGX-113) With ENHANZE® Drug Delivery Technology

SAN DIEGO, July 17, 2019 /PRNewswire/ —¬†Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced that argenx has dosed the first subject in a phase 1 clinical trial … […]

No Picture
San Diego Biotech Jobs

Associate Director of Late-Stage Analytics and Bioassay Development – Synthorx, Inc. – La Jolla, CA

Synthorx is a biotechnology company using a novel synthetic biology platform for the discovery and development of transformational protein therapeutics. Using…From Indeed – Wed, 17 Jul 2019 03:27:21 GMT – View all La Jolla, CA jobs […]

No Picture
San Diego Biotech Jobs

Director/Senior Director of Later Stage Process Development CMC – Synthorx, Inc. – La Jolla, CA

Synthorx is a biotechnology company using a novel synthetic biology platform for the discovery and development of transformational protein therapeutics.We are…From Indeed – Wed, 17 Jul 2019 03:19:23 GMT – View all La Jolla, CA jobs […]